NEXENTIS TECHNOLOGIES INC. Stockholders' Equity Attributable to Noncontrolling Interest
NEXENTIS TECHNOLOGIES INC. (NXTS) had Stockholders' Equity Attributable to Noncontrolling Interest of -$123.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$123.00K.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$111.00K.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$280.00K.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$254.00K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest | Stockholders' Equity Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | -$123.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$111.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$280.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$254.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$214.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$242.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$176.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$137.42K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$86.92K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$74.22K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$22.00K 10-K · filed 2025-03-31 | -$21.43K 10-K · filed 2024-04-01 |
| 2023-09-30 | $32.26K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$122.05K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$116.71K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$109.04K 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$96.20K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$87.17K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$79.92K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$70.67K 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$61.06K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$48.73K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$30.27K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | -$29.28K 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$28.28K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$26.28K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | -$24.09K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$21.05K 10-K · filed 2021-03-29 | |
| 2018-12-31 | -$6.71K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |